Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy
Endocrinology and Metabolism, 10/30/09
Blumer RME et al. – HIV–infected patients on antiretroviral therapy frequently develop changes in body fat distribution and disturbances in glucose metabolism, associated with reduced adiponectin levels. Because adiponectin, principally the high–molecular–weight (HMW) form, has insulin–sensitizing properties, the authors investigated the effects of an increase in adiponectin on glucose metabolism in HIV–lipodystrophy. Acknowledging the limited statistical power of the small study, these findings, if confirmed by larger studies, could question the importance of adiponectin in regulating glucose metabolism in HIV–lipodystrophy.
Today in HIV/Immunodeficiency...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of Increasing Emergency Department Patients' Self-perceived Risk for Being Human Immunodeficiency Virus (HIV) Infected Through Audio Computer Self-interview–based Feedback About Reported HIV Risk Behaviors
Academic Emergency Medicine, 11/11/09
HIV-Specific Health Care Utilization and Mortality among Tuberculosis/HIV Coinfected Persons
AIDS Patient Care and STDs, 10/06/09
Acyclovir: a new use for an old drug
Current Opinion in Infectious Diseases, 10/28/09
Article Search
Sponsor


See Latest Articles


